HCSG
Healthcare Services Group Inc
20.80$
-1.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.0% | +0.1% | -0.5% | +0.8% | +1.2% | +0.9% | -2.5% | +0.3% | +0.4% | +0.9% | +0.7% | |
| – | +7.2% | +1.5% | -1.2% | +0.9% | -3.7% | +3.3% | -7.4% | +9.1% | -0.7% | +4.3% | -5.4% | |
| – | +73.5% | -0.6% | -51.0% | +2.4% | +215.0% | -24.5% | +74.8% | +10.7% | +29.5% | -15.5% | +17.2% | |
| – | +21.6% | -12.1% | -18.5% | -1.6% | +30.8% | -15.4% | +42.9% | +8.2% | +14.9% | -12.4% | +12.5% | |
| – | +3.9% | +6.2% | -2.0% | +1.9% | -5.9% | +1.2% | -16.3% | +1.7% | +1.6% | +2.4% | -5.4% | |
| – | -3.7% | -2.4% | -1.0% | -4.5% | -1.7% | +3.1% | +0.5% | -0.9% | -2.4% | -5.4% | -0.3% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +6.0% | +0.0% | +0.0% | -0.3% | +0.0% | +7.5% | |
| – | -5.3% | -5.5% | -5.9% | -6.2% | -6.6% | +6.1% | -17.5% | -7.9% | -8.5% | -9.3% | +107.6% | |
| – | +12.2% | -5.0% | -0.3% | -3.4% | -0.5% | -2.1% | +5.3% | -5.2% | -3.5% | +1.2% | +0.3% | |
| – | +15.5% | -3.5% | +0.1% | -5.9% | -2.4% | +3.2% | +7.6% | -8.5% | -12.9% | +13.5% | -2.7% | |
| – | -28.0% | +23.5% | -25.0% | -16.7% | -66.4% | – | – | -8.0% | -29.9% | -1.2% | +21.0% | |
| – | +17.9% | -12.4% | -1.0% | +6.1% | +5.9% | -2.9% | -1.1% | +4.9% | -5.3% | +7.4% | +3.6% | |
| – | +3.4% | +3.9% | -0.7% | +3.7% | +2.3% | +2.9% | -7.2% | +4.0% | +2.9% | +0.7% | +1.0% | |
| – | +8.6% | +8.3% | -0.9% | +7.1% | +5.6% | +7.7% | -13.4% | +20.5% | +12.4% | +9.2% | +7.3% | |
| – | -0.7% | +0.2% | -0.3% | +0.1% | +0.1% | 0.0% | -0.7% | +0.1% | -2.5% | -0.8% | -0.8% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.